More than Expectorant: New Scientific Data on Ambroxol in the Context of the Treatment of Bronchopulmonary Diseases
Journal Title: Journal of Intensive and Critical Care - Year 2017, Vol 3, Issue 3
Abstract
Background:Ambroxol has been established for decades in the treatment of acute and chronic respiratory diseases. A reassessment of the benefit-risk was conducted recently. Objective: What new scientific data, relevant for the treatment of bronchopulmonary diseases, were published in the last decade? Method: Systematic literature search via http://www.pubmed.gov with the search term “ambroxol”, covering the publication period from 2006 to 2015. Nonrelevant publications were excluded manually. Results: 64 relevant publications could be identified covering both, clinical and preclinical research. Conclusion: The traditional indication of ambroxol as an expectorant is confirmed but new results revealed a better understanding of the various mechanisms of action of ambroxol and the benefits for special patient populations. The available data suggest the use of ambroxol as an adjuvant in anti-infective therapy, particularly in case of infections with biofilm-producing pathogens. Lungprotective properties are discussed in both infants and severely ill adult patients. First results in rare diseases, such as lysosomal storage disorders, show a potential benefit of ambroxol. However, final evidence for the clinical relevance in this special field has yet to be provided.
Authors and Affiliations
Manuel Plomer
Keywords
Related Articles
- EP ID EP301008
- DOI 10.21767/2471-8505.100096
- Views 58
- Downloads 0
Sleep Disturbances and Critical Illness
Patients in the intensive care unit are at risk for developing sleep disturbances. This article describes the etiologic factors associated with sleep disturbances in the intensive care setting, effects of sleep disturban...
Should We Care about Driving Pressure during Assisted Mechanical Ventilation?
During passive mechanical ventilation, at absence of dynamic hyperinflation, driving pressure of respiratory system (ΔP) is defined as static end-inspiratory plateau pressure (Pplat) minus external positive end-expirator...
Individualizing Optimal Fluid Resuscitation in Patients with Major Burns: Emerging Role for Hydrocortisone, Proteinuria and Brain Natriuretic Peptide
During the last decades tremendous progress has been made in the acute resuscitation of patients with major burns [1,2]. The recognition that large amounts of fluids should be infused during the first hours to days, due...
A Retrospective Study on the Compliance with Surviving Sepsis Campaign Guideline in Patients with Sepsis Admitted to Intensive Care Unit in Hong Kong
The global incidence of sepsis is increasing due to earlier recognition, but mortality from sepsis still remains high. Local data on the management according to the Surviving Sepsis Campaign Care Bundle is still lacking....
Reduction of Blood Pressure by Electro Acupuncture in Mild to Moderate Hypertensive Patients: Randomized Controlled Trial
There is a growing interest in integrative medical treatments such as acupuncture on hypertension although therapy to control high blood pressure (BP) is available. We have demonstrated in a series of experimental invest...